Charles River Laboratories International (CRL) vs NRC Health (NRC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Charles River Laboratories International (CRL) has outperformed NRC Health (NRC) over the past year, gaining 71.8% versus a gain of 71.3%. Over five years, CRL leads with a -26.2% price change compared with -52.4% for NRC. Charles River Laboratories International is the larger company by market cap ($14.63 billion vs $445.5 million), about 32.8 times the size.
On valuation, NRC Health trades at a lower forward P/E (19.2x vs 23.8x for Charles River Laboratories International). NRC Health pays a dividend yielding 2.98%, while Charles River Laboratories International does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRL | NRC |
|---|---|---|
| Share price | $303.66 | $20.14 |
| Market cap | $14.63B | $445.49M |
| 1-day change | +1.90% | -1.37% |
| YTD return | +49.39% | +8.79% |
| 1-year return | +71.79% | +71.31% |
| 5-year return | -26.15% | -52.38% |
| P/E ratio (TTM) | — | 83.92 |
| Forward P/E | 23.77 | 19.18 |
| EPS (TTM) | $-4.80 | $0.24 |
| Dividend yield | 0.00% | 2.98% |
| Annual dividend | $0.00 | $0.60 |
| Revenue (latest FY) | $4.02B | — |
| Revenue growth (YoY) | -0.85% | — |
| Net income (latest FY) | $-144.34M | — |
| Operating margin | 0.63% | — |
| Net margin | -3.59% | — |
| 52-week high | $333.30 | $23.68 |
| 52-week low | $146.20 | $11.01 |
| Distance from 52-week high | -8.89% | -14.95% |
| Analyst consensus | buy | none |
| Avg. price target upside | +0.44% | +29.10% |
| Average volume | 956.13K | 115.97K |
| Shares outstanding | 48.17M | 22.12M |
| Employees | 18,300 | 357 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Commercial Physical & Biological Resarch |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Charles River Laboratories International is about 32.8 times larger than NRC Health by market value ($14.63B vs $445.49M).
- NRC Health offers a meaningfully higher dividend yield (2.98% vs 0.00%).
About Charles River Laboratories International
CRL stock →Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 18,300 employees
About NRC Health
NRC stock →NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 357 employees
CRL vs NRC FAQ
Which is bigger, Charles River Laboratories International or NRC Health?
Charles River Laboratories International (CRL) is larger, with a market capitalization of $14.63B compared with $445.49M for NRC Health (NRC).
Which stock has performed better over the past year, CRL or NRC?
CRL returned +71.79% over the past 12 months, compared with +71.31% for NRC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Charles River Laboratories International or NRC Health?
NRC Health pays a dividend yielding 2.98%, while Charles River Laboratories International does not currently pay a regular dividend.
Are Charles River Laboratories International and NRC Health in the same industry?
Yes. Both are classified in the Biotechnology: Commercial Physical & Biological Resarch industry within the Health Care sector.